Results 231 to 240 of about 323,198 (362)
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard +5 more
wiley +1 more source
Screening for lung cancer: A systematic review of overdiagnosis and its implications
Low‐dose computed tomography (CT) screening for lung cancer may increase overdiagnosis compared to no screening, though the risk is likely low versus chest X‐ray. Our review of 8 trials (84 660 participants) shows added costs. Further research with strict adherence to modern nodule management strategies may help determine the extent to which ...
Fiorella Karina Fernández‐Sáenz +12 more
wiley +1 more source
Lessons from the field: implementing pharmacy services in the Tanzanian hospital setting. [PDF]
Lambert M +6 more
europepmc +1 more source
The Clinical Evaluation of Drug Information Provided by the Pharmacists in the Intensive Care Unit
Masaharu Imaura +6 more
openalex +2 more sources
The contribution of community pharmacy to improving the public’s health: summary report of the literature review 1990–2007 [PDF]
Anderson, Claire +2 more
core +1 more source
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece +18 more
wiley +1 more source
Report on the implementation, evaluation and new technologies of practice guidelines and information materials [PDF]
Alvarez, Javier +14 more
core

